全文获取类型
收费全文 | 5748篇 |
免费 | 381篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 292篇 |
妇产科学 | 80篇 |
基础医学 | 609篇 |
口腔科学 | 84篇 |
临床医学 | 455篇 |
内科学 | 1255篇 |
皮肤病学 | 104篇 |
神经病学 | 356篇 |
特种医学 | 126篇 |
外科学 | 1063篇 |
综合类 | 104篇 |
一般理论 | 3篇 |
预防医学 | 360篇 |
眼科学 | 226篇 |
药学 | 512篇 |
中国医学 | 20篇 |
肿瘤学 | 389篇 |
出版年
2023年 | 52篇 |
2022年 | 103篇 |
2021年 | 220篇 |
2020年 | 129篇 |
2019年 | 172篇 |
2018年 | 211篇 |
2017年 | 136篇 |
2016年 | 175篇 |
2015年 | 176篇 |
2014年 | 255篇 |
2013年 | 274篇 |
2012年 | 383篇 |
2011年 | 379篇 |
2010年 | 235篇 |
2009年 | 208篇 |
2008年 | 335篇 |
2007年 | 383篇 |
2006年 | 383篇 |
2005年 | 310篇 |
2004年 | 289篇 |
2003年 | 266篇 |
2002年 | 214篇 |
2001年 | 91篇 |
2000年 | 60篇 |
1999年 | 51篇 |
1998年 | 51篇 |
1997年 | 29篇 |
1996年 | 40篇 |
1995年 | 18篇 |
1994年 | 23篇 |
1993年 | 30篇 |
1992年 | 29篇 |
1991年 | 33篇 |
1990年 | 29篇 |
1989年 | 30篇 |
1988年 | 38篇 |
1987年 | 35篇 |
1986年 | 30篇 |
1985年 | 17篇 |
1984年 | 22篇 |
1983年 | 16篇 |
1982年 | 11篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1977年 | 13篇 |
1975年 | 13篇 |
1974年 | 14篇 |
1973年 | 13篇 |
1972年 | 14篇 |
1970年 | 19篇 |
排序方式: 共有6142条查询结果,搜索用时 15 毫秒
61.
62.
63.
Natasha Purai Arora Mouhammed Joumaa Howard Rosman Raj Mehta 《The American journal of the medical sciences》2017,353(6):597-602
Left main coronary artery (LMCA) thrombosis with acute myocardial infarction is a rare condition with very high mortality. The low incidence of this condition and exclusion of patients with LMCA thrombosis from clinical trials prevent the development of optimal management strategy in these patients. Therefore, there are no clear-cut guidelines describing an evidence-based approach for this condition. We describe a patient with LMCA thrombosis presenting with acute myocardial infarction, who was found to have hypercoagulable state related to homocysteinemia on further work-up. This case highlights the challenges faced during the management of this rare condition due to lack of clear-cut guidelines describing an evidence-based approach. 相似文献
64.
65.
66.
ObjectiveTo investigate the antibacterial potential of 5 different metal oxide nanoparticles against antibiotic resistant bacterial pathogens viz., Pseudomonas aeruginosa, Klebsiella sp. Streptococcus pneumoniae, Staphylococcus aureus and Streptococcus sp.MethodsThe antibacterial activity of the five different nanoparticles was assessed by well diffusion method. Different concentrations of the nanoparticles were analyzed by MIC and MBC techniques. Finally the potential MgO nanoparticle was also subjected for the time kill assay method.ResultsThe results reveal that, the MgO nanoparticle showed maximum sensitivity [(16.00±0.53) mm dia] against Streptococcus pneumoniae and showed minimum sensitivity against Klebsiella sp. [(9.00±0.31) mm dia]. None of the nanoparticles showed sensitivity against the Streptococcus sp. The MIC result reveals that, the MgO nanoparticle showed maximum inhibition at a concentration of 10 μ g against Streptococcus pneumoniae. Moreover, the time kill assay reveals that, the bacterial growth was inhibited from the 2nd h onwards at a concentration of 10μ g.ConclusionsIt is concluded from the present findings that, the MgO nanoparticle could be used as an alternative antibacterial agent after completing successful in vivo trials. 相似文献
67.
P. Prithvi Raj MD C. Stratton Hill Jr MD Gabor Racz MD James Heavner DVM PhD Martin Grabois MD Lynn Neill MD William Willis Jr MD PhD C. M. Schade MD PhD Ralph Rashbaum MD Aaron Calodney MD Allen W. Burton MD Judson Somerville MD 《Pain practice》2012,12(1):57-65
Abstract: The idea of forming a Texas Pain Society came to the Founders in 1987 due to disparity and deficiencies in the practice of pain management in the United States and, in particular, the State of Texas. The Founders considered very carefully the implication of forming such a society. They diligently mapped out the mission and goals of the Texas Pain Society in those early formative years. This report is the history of Texas Pain Society as the activities unfolded from 1989 to 2011. The reader may question why there is a need to tell such a story. We believe strongly that, with disparities of standards of practice in pain medicine and poor recognition of advances in pain management, this scenario is quite common in many states and countries. The practitioners of pain management in these regions certainly must have considered getting together and forming a consensus on the standards of practice in their communities. This historical report of the Texas Pain Society provides the relevant information necessary and the efforts to be made for a society’s mission to achieve its goals and have an ongoing impact in its own region. We hope that we have shed some light on a process for the formation of a regional pain society such as ours. ? 相似文献
68.
Angelman syndrome (AS) is a neurodevelopmental disorder caused by the loss of function of the maternal UBE3A gene. The hippocampus is one of the most prominently affected brain regions in AS model mice, manifesting in severe hippocampal-dependent memory and plasticity deficits. Previous studies in AS mice reported an elongated axon initial segment (AIS) in pyramidal neurons (PNs) of the hippocampal CA1 region. These were the first reports in mammals to show AIS elongation in vivo. Correspondingly, this AIS elongation was linked to enhanced expression of the α1 subunit of Na+/K+-ATPase (α1-NaKA). Recently, it was shown that selective pharmacological inhibition of α1-NaKA by marinobufagenin (MBG) in adult AS mice rescued the hippocampal-dependent deficits via normalizing their compromised activity-dependent calcium (Ca+2) dynamics. In the herein study, we showed that a chronic selective α1-NaKA inhibition reversed the AIS elongation in hippocampal CA1 PNs of adult AS mice, and differentially altered their excitability and intrinsic properties. Taken together, our study is the first to demonstrate in vivo structural plasticity of the AIS in a mammalian model, and further elaborates on the modulatory effects of elevated α1-NaKA levels in the hippocampus of AS mice.Subject terms: Cellular neuroscience, Autism spectrum disorders, Developmental disorders 相似文献
69.
70.
N. Rajšić 《Clinical neurophysiology》2013,124(7):e11-e12